caa a22 4500 605543534 CHVBK 20210128100927.0 cr unu---uuuuu 210128e20151001xx s 000 0 eng 10.1007/s00109-015-1296-9 doi (NATIONALLICENCE)springer-10.1007/s00109-015-1296-9 miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development [Elektronische Daten] [Mathieu Latreille, Karolin Herrmanns, Neil Renwick, Thomas Tuschl, Maciej Malecki, Mark McCarthy, Katharine Owen, Thomas Rülicke, Markus Stoffel] The Author(s), 2015 MiRNA-375 nationallicence Pancreatic β-cells nationallicence Biomarker nationallicence Diabetes nationallicence β-cell mass nationallicence Latreille Mathieu Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Otto-Stern Weg. 7, 8093, Zurich, Switzerland aut Herrmanns Karolin Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Otto-Stern Weg. 7, 8093, Zurich, Switzerland aut Renwick Neil Howard Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, 1230 York Avenue, Box 186, 10065, New York, NY, USA aut Tuschl Thomas Howard Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, 1230 York Avenue, Box 186, 10065, New York, NY, USA aut Malecki Maciej Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland aut McCarthy Mark Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Old Road, Headington, OX3 7LJ, Oxford, UK aut Owen Katharine Oxford NIHR Biomedical Research Centre, Churchill Hospital, Old Road, Headington, OX3 7LJ, Oxford, UK aut Rülicke Thomas Institute of Laboratory Animal Science, University of Veterinary Medicine, Vienna, Austria aut Stoffel Markus Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Otto-Stern Weg. 7, 8093, Zurich, Switzerland aut Journal of Molecular Medicine Springer Berlin Heidelberg 93/10(2015-10-01), 1159-1169 0946-2716 93:10<1159 2015 93 109 https://doi.org/10.1007/s00109-015-1296-9 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s00109-015-1296-9 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Latreille Mathieu Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Otto-Stern Weg. 7, 8093, Zurich, Switzerland aut NATIONALLICENCE 700 1- Herrmanns Karolin Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Otto-Stern Weg. 7, 8093, Zurich, Switzerland aut NATIONALLICENCE 700 1- Renwick Neil Howard Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, 1230 York Avenue, Box 186, 10065, New York, NY, USA aut NATIONALLICENCE 700 1- Tuschl Thomas Howard Hughes Medical Institute, Laboratory of RNA Molecular Biology, The Rockefeller University, 1230 York Avenue, Box 186, 10065, New York, NY, USA aut NATIONALLICENCE 700 1- Malecki Maciej Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland aut NATIONALLICENCE 700 1- McCarthy Mark Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Old Road, Headington, OX3 7LJ, Oxford, UK aut NATIONALLICENCE 700 1- Owen Katharine Oxford NIHR Biomedical Research Centre, Churchill Hospital, Old Road, Headington, OX3 7LJ, Oxford, UK aut NATIONALLICENCE 700 1- Rülicke Thomas Institute of Laboratory Animal Science, University of Veterinary Medicine, Vienna, Austria aut NATIONALLICENCE 700 1- Stoffel Markus Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zurich), Otto-Stern Weg. 7, 8093, Zurich, Switzerland aut NATIONALLICENCE 773 0- Journal of Molecular Medicine Springer Berlin Heidelberg 93/10(2015-10-01), 1159-1169 0946-2716 93:10<1159 2015 93 109